The Max Planck Digital Library has renewed the read and publish agreement with The Company of Biologists. The agreement will run from 1 January 2024 until 31 December 2026, and corresponding authors at Max Planck Society’s 86 institutes can continue to publish research articles immediately Open Access (OA) in our hybrid journals (Development, Journal of Cell Science and Journal of Experimental Biology) and our fully Open Access journals (Disease Models & Mechanisms and Biology Open) without paying an article processing charge (APC). Researchers at participating institutions also benefit from unlimited access to our hybrid journals, including their full archives dating back to 1853.
“We at the MPDL are delighted to extend our collaboration with The Company of Biologists, which means we can continue to offer our researchers the possibility to publish open access in all the publisher’s journals as well as access to all previously published content," says Ádám Dér, Head of the Scientific Information Provision at MPDL. "Providing these opportunities to our authors is at the heart of our overall strategy in the world of scholarly publishing, in line with the Max Planck Society’s vision of openness, which in turn reflects the principles of the OA2020 Initiative and the Berlin Declaration on Open Access.”
Read the full announcement here